Arcellx, Inc. Share Price: ACLX (Arcellx, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Arcellx, Inc. share price today?

Accepted Answer

Arcellx, Inc. (ACLX) share price today is {{live_price}}.

Question 2

Can Indians buy Arcellx, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Arcellx, Inc. (ACLX) from India.

With INDmoney, you can buy Arcellx, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Arcellx, Inc. at zero transaction cost.

Question 3

How can I buy Arcellx, Inc. shares from India?

Accepted Answer

It is very easy to buy Arcellx, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Arcellx, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Arcellx, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Arcellx, Inc. stocks?

Accepted Answer

To start investing in Arcellx, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Arcellx, Inc.

Accepted Answer

Today’s highest price of Arcellx, Inc. (ACLX) is {{1_rba_end}}.

Today’s lowest price of Arcellx, Inc. (ACLX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Arcellx, Inc.

Accepted Answer

Today's market capitalisation of Arcellx, Inc. ACLX is 5.2B

Question 8

What is the 52 Week High and Low Range of Arcellx, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Arcellx, Inc. is down from its 52 Week High?

Accepted Answer

Arcellx, Inc. (ACLX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Arcellx, Inc. is up from its 52 Week low?

Accepted Answer

Arcellx, Inc. (ACLX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Arcellx, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Arcellx, Inc.

Accepted Answer

Mr. Rami  Elghandour is the current Chief Executive Officer (CEO) of Arcellx, Inc..

Period	Arcellx, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	53.82%	3.6%	0.0%
6 Months	86.27%	10.2%	0.0%
1 Year	199.14%	19.6%	0.0%
3 Years	476.55%	16.8%	-23.0%

Market Capitalization	5.2B
Book Value	$9.08
Earnings Per Share (EPS)	-1.04
Wall Street Target Price	88.81

Profit Margin	-37.23%
Operating Margin TTM	-127.79%

Return On Assets TTM	-7.43%
Return On Equity TTM	-13.8%

Revenue TTM	144.7M
Revenue Per Share TTM	2.84
Quarterly Revenue Growth YOY	91.5%
Gross Profit TTM	0.0
EBITDA	-77.4M
Diluted Eps TTM	-1.04
Quarterly Earnings Growth YOY	0.0

Arcellx, Inc. (ACLX)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Arcellx, Inc. Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.55
EPS Estimate Next Year	-2.31
EPS Estimate Current Quarter	-0.53
EPS Estimate Next Quarter	-0.49

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Arcellx, Inc.	12.65%	86.27%	199.14%	476.55%	476.55%
Regeneron Pharmaceuticals, Inc.	-9.28%	10.06%	24.53%	74.0%	232.45%
Novo Nordisk A/s	-4.54%	-5.72%	21.59%	126.2%	349.01%
Alnylam Pharmaceuticals, Inc.	8.87%	102.98%	82.67%	44.83%	241.09%
Vertex Pharmaceuticals Incorporated	5.0%	20.77%	31.37%	158.16%	163.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Arcellx, Inc.	NA	NA	NA	-1.55	-0.14	-0.07	NA	9.08
Regeneron Pharmaceuticals, Inc.	26.41	26.41	1.37	44.9	0.17	0.08	NA	261.41
Novo Nordisk A/s	40.21	40.21	1.81	3.36	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.42	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.59	0.18	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Arcellx, Inc.	Buy	$5.2B	476.55%	NA	-37.23%
Regeneron Pharmaceuticals, Inc.	Buy	$110.0B	232.45%	26.41	32.04%
Novo Nordisk A/s	Buy	$529.8B	349.01%	40.21	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$38.1B	241.09%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$128.7B	163.17%	32.84	-4.74%

Organization	Arcellx, Inc.
Employees	130
CEO	Mr. Rami Elghandour
Industry	Healthcare